Search for dissertations about: "cardiovascular agents"

Showing result 1 - 5 of 70 swedish dissertations containing the words cardiovascular agents.

  2. 1. Polymer-shelled Ultrasound Contrast Agents : Characterization and Application

    Author : Dmitry Grishenkov; Leif Kari; Lars-Åke Brodin; Michel Versluis; KTH; []
    Keywords : TEKNIK OCH TEKNOLOGIER; ENGINEERING AND TECHNOLOGY; TEKNIK OCH TEKNOLOGIER; ENGINEERING AND TECHNOLOGY; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; ultrasound; contrast agents; microbubbles; polymer; perfusion; Acoustics; Akustik; Material physics with surface physics; Materialfysik med ytfysik; Cardiovascular medicine; Kardiovaskulär medicin; Cardiology; Kardiologi;

    Abstract : Ultrasound-based imaging technique is probably the most used approach for rapid investigationand monitoring of anatomical and physiological conditions of internal organs and tissues.Ultrasound-based techniques do not require the use of ionizing radiation making the tests anexceptionally safe and painless. READ MORE

  4. 2. Experimental Aspects of Topical Haemostatic Agents

    Author : Katarina Björses; Vaskulära sjukdomar - kliniska studier; []
    Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; platelet stimulation; coagulation factors; experimental bleeding models; topical haemostatic agents;

    Abstract : Control of haemorrhage is vital in all operative settings. As complement to traditional surgical haemostatic techniques, a heterogeneous collection of absorbable substances with haemostatic capacity have been developed; topical haemostatic agents. READ MORE

  5. 3. The Utility of Ultrasmall Superparamagnetic Iron Oxide Contrast Agents for Cardiovascular Magnetic Resonance Imaging

    Author : Lars Johansson; Håkan Ahlström; Hans-Jørgen Smith; Uppsala universitet; []
    Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Radiology; Magnetic resonance imaging; Contrast agent; Iron Oxide; Cardiovascular; Radiologisk forskning; Radiological research; Radiologisk forskning;

    Abstract : The purpose of this thesis was to investigate the utility of the Ultrasmall Superparamagnetic Iron Oxide Particle (USPIO), NC100150 Injection for assessment of macro- and microvascular morphology and function using magnetic resonance imaging. The feasibility of NC100150 Injection was tested for the following applications: Coronary angiography, Thrombus detection, Cardiac function, Myocardial perfusion, Assessment of myocardial blood volume and water exchange and finally assessment of endothelial integrity of the myocardium. READ MORE

  6. 4. Acute Myocardial Infarction: The Relationship between Duration of Ischaemia and Infarct Size in Humans - Assessment by MRI and SPECT

    Author : Erik Hedström; Lund Klinisk fysiologi; []
    Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Cardiovascular system; Fysiologi; Physiology; humans; cardiac troponin T; creatine kinase isoenzyme MB; delayed contrast-enhanced magnetic resonance imaging; single photon emission computed tomography; myocardial perfusion; myocardial infarct size; myocardium at risk; duration of ischaemia; Kardiovaskulära systemet;

    Abstract : The effect of duration of ischaemia on final infarct size is well established in animal studies, but not fully evaluated in humans. Delayed contrast-enhanced magnetic resonance imaging (DE-MRI) can be used to distinguish between viable and non-viable myocardium and thus to quantify infarct size. READ MORE

  7. 5. Clinical consequences after heart transplantation with reference to osteoporosis, renal function, and immunosuppression. Experiences from Skåne University Hospital in Lund 1988-2019

    Author : Eveline Löfdahl; Kardiologi; []
    Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Heart Transplantation; Osteoporosis; chronic kidney disase; immunosuppressive agents;

    Abstract : Background. Heart transplantation (HT) remains the ultimate final therapy for patients with end-stage heart failure. To prevent rejection of the allograft, life-long immunosuppressive therapy is required. READ MORE